Swiss National Bank - TARO PHARMACEUTICAL INDS LTD ownership

Quarter-by-quarter ownership
Swiss National Bank ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$788,139
-0.6%
20,9000.0%0.00%0.0%
Q2 2023$792,737
+59.0%
20,900
+2.0%
0.00%
Q1 2023$498,560
-23.7%
20,500
-8.9%
0.00%
Q4 2022$653,400
-3.2%
22,5000.0%0.00%
Q3 2022$675,000
-17.1%
22,5000.0%0.00%
-100.0%
Q2 2022$814,000
-15.6%
22,500
+0.9%
0.00%0.0%
Q1 2022$965,000
-7.8%
22,300
+6.7%
0.00%0.0%
Q4 2021$1,047,000
-22.4%
20,900
-1.4%
0.00%0.0%
Q3 2021$1,349,000
-11.6%
21,2000.0%0.00%0.0%
Q2 2021$1,526,000
-5.1%
21,200
-2.8%
0.00%0.0%
Q1 2021$1,608,000
+0.4%
21,8000.0%0.00%0.0%
Q4 2020$1,601,000
-69.8%
21,800
-53.7%
0.00%
-83.3%
Q3 2017$5,308,000
+1.9%
47,100
+1.3%
0.01%0.0%
Q2 2017$5,211,000
-16.0%
46,500
-12.6%
0.01%
-25.0%
Q1 2017$6,204,000
+3.4%
53,200
-6.7%
0.01%
-11.1%
Q4 2016$6,000,000
-57.3%
57,000
-55.2%
0.01%
-60.9%
Q3 2016$14,057,000
-25.1%
127,200
-1.3%
0.02%
-23.3%
Q2 2016$18,768,000
+338.2%
128,900
+313.1%
0.03%
+275.0%
Q1 2016$4,283,000
-6.1%
31,200
+5.8%
0.01%
-27.3%
Q4 2015$4,559,00029,5000.01%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
ISZO CAPITAL MANAGEMENT LP 1,104,168$154,849,00080.27%
Consonance Capital Management LP 378,372$53,063,0007.89%
Moab Capital Partners 93,133$13,061,0006.27%
Greywolf Capital Management LP 277,936$38,978,0005.77%
Perceptive Advisors 301,333$42,260,0004.15%
Valentine Capital Asset Management, Inc. 141,270$19,812,0003.81%
Raging Capital Management, LLC 253,236$35,514,0003.78%
Ativo Capital Management LLC 18,058$2,532,0001.10%
Geduld E E 8,000$1,122,0000.70%
Assured Investment Management LLC 192,389$26,981,0000.46%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders